{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:55:24Z","timestamp":1791248124482,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,2,13]],"date-time":"2009-02-13T00:00:00Z","timestamp":1234483200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1007\/s00535-008-2307-1","type":"journal-article","created":{"date-parts":[[2009,2,12]],"date-time":"2009-02-12T11:55:46Z","timestamp":1234439746000},"page":"197-203","source":"Crossref","is-referenced-by-count":60,"title":["Thiopurine S-methyltransferase and inosine triphosphate pyrophosphohydrolase genes in Japanese patients with inflammatory bowel disease in whom adverse drug reactions were induced by azathioprine\/6-mercaptopurine treatment"],"prefix":"10.1007","volume":"44","author":[{"given":"Kan","family":"Uchiyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tateki","family":"Yamane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyotaka","family":"Fujise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisao","family":"Tajiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,2,13]]},"reference":[{"key":"2307_CR1","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00008571-200208000-00003","volume":"12","author":"M. Schwab","year":"2002","unstructured":"Schwab M, Schaffeler E, Marx C, Fischer C, Lang T, Behrens C, et al. Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease: impact of thiopurine S-methyltransferase polymorphism. Pharmacogenetics 2002;12: 429\u2013436.","journal-title":"Pharmacogenetics"},{"key":"2307_CR2","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1046\/j.1365-2036.2002.01353.x","volume":"16","author":"A. Ansari","year":"2002","unstructured":"Ansari A, Hassan C, Dulay J, Marinaki A, Shobowale-Bakre EM, Seed P, et al. Thiopurine methyltransferase activity and the use of azathioprine in inflammatory bowel disease. Aliment Pharmacol Ther 2002;16:1743\u20131750.","journal-title":"Aliment Pharmacol Ther"},{"key":"2307_CR3","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/gut.51.2.143","volume":"51","author":"L. Lennard","year":"2002","unstructured":"Lennard L. TPMT in the treatment of Crohn\u2019s disease with azathioprine. Gut 2002;51:143\u2013146.","journal-title":"Gut"},{"key":"2307_CR4","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1365-2125.2001.01371.x","volume":"51","author":"T. Kubota","year":"2001","unstructured":"Kubota T, Chiba K. Frequencies of thiopurine S-methyltransferase mutant alleles (TPMT*2, *3A, *3B, *3C) in 151 healthy Japanese subjects and the inheritance of TPMT*3C in the family of a propositus. Br J Clin Pharmacol 2001;51: 475\u2013477.","journal-title":"Br J Clin Pharmacol"},{"key":"2307_CR5","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ab.2004.11.038","volume":"337","author":"A. Ishiguro","year":"2005","unstructured":"Ishiguro A, Kubota T, Soya Y, Sasaki H, Yagyu O, Takarada Y, et al. High-throughput detection of multiple genetic polymorphisms influencing drug metabolism with mismatch primers in allele specific polymerase chain reaction. Anal Biochem 2005;337: 256\u2013261.","journal-title":"Anal Biochem"},{"key":"2307_CR6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00008571-200403000-00006","volume":"14","author":"A.M. Marinaki","year":"2004","unstructured":"Marinaki AM, Ansari A, Duley JA, Arenas M, Sumi S, Lewis CM, et al. Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase). Pharmacogenetics 2004;14: 181\u2013187.","journal-title":"Pharmacogenetics"},{"key":"2307_CR7","first-page":"593","volume":"13","author":"D.A. Clarke","year":"1953","unstructured":"Clarke DA, Philips FS, Sternberg SS, Stock CC, Elion GB, Hitchings H. 6-mercaptopurine: effects in mouse sarcoma 180 and in normal animals. Cancer Res 1953;13:593\u2013604.","journal-title":"Cancer Res"},{"key":"2307_CR8","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1182\/blood.V8.11.965.965","volume":"8","author":"J.H. Burchenal","year":"1953","unstructured":"Burchenal JH, Murphy ML, Ellison RR, Sykes MP, Tan LA, Leone LA, et al. Clinical evaluation of a new antimetabolite, 6-mercaptopurine, in the treatment of leukemia and allied diseases. Blood 1953;8:965\u2013999.","journal-title":"Blood"},{"key":"2307_CR9","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0140-6736(65)90866-4","volume":"18","author":"I. Lorenzen","year":"1965","unstructured":"Lorenzen I, Videbeak A. Treatment of collagen disease with cytostatics. Lancet 1965;18:558\u2013561.","journal-title":"Lancet"},{"key":"2307_CR10","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/bmj.1.5641.420","volume":"15","author":"M. Mason","year":"1969","unstructured":"Mason M, Currey HL, Barnes CG, Dunne JF, Hazleman BL, Strickland ID. Azathioprine in rheumatoid arthritis. Br Med J 1969;15:420\u2013422.","journal-title":"Br Med J"},{"key":"2307_CR11","first-page":"898","volume":"26","author":"G.B. Elion","year":"1967","unstructured":"Elion GB. Symposium on immunosuppressive drugs. Biochemistry and pharmacology of purine analogues. Fed Proc 1967;26: 898\u2013904.","journal-title":"Fed Proc"},{"key":"2307_CR12","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0140-6736(69)90325-0","volume":"2","author":"B.N. Brooke","year":"1969","unstructured":"Brooke BN, Hoffmann DC, Swarbrick ET. Azathioprine for Crohn\u2019s disease. Lancet 1969;2:612\u2013614.","journal-title":"Lancet"},{"key":"2307_CR13","first-page":"651","volume":"32","author":"R.M. Weinshilboum","year":"1980","unstructured":"Weinshilboum RM, Sladek SL. Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Hum Genet 1980;32:651\u2013662.","journal-title":"Am J Hum Genet"},{"key":"2307_CR14","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1097\/FPC.0b013e3282ef642b","volume":"17","author":"M. Lindqvist","year":"2007","unstructured":"Lindqvist M, Skoglund K, Karlgren A, Soederkvist P, Peterson C, Kidhall I, et al. Explaining TPMT genotype\/phenotype discrepancy by haplotyping of TPMT*3A and identification of a novel sequence variant, TPMT*23. Pharmacogenet Genomics 2007;17: 891\u2013895.","journal-title":"Pharmacogenet Genomics"},{"key":"2307_CR15","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00008571-200104000-00012","volume":"11","author":"K. Kumagai","year":"2001","unstructured":"Kumagai K, Hiyama K, Ishioka S, Sato H, Yamanishi Y, McLeod HL, et al. Allelotype frequency of the thiopurine methyltransferase (TPMT) gene in Japanese. Pharmacogenetics 2001;11: 275\u2013278.","journal-title":"Pharmacogenetics"},{"key":"2307_CR16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0027-5107(00)00004-X","volume":"448","author":"M. Hiratsuka","year":"2000","unstructured":"Hiratsuka M, Inoue T, Omori F, Agatsuma Y, Mizugaki M. Genetic analysis of thiopurine methyltransferase polymorphism in a Japanese population. Mutat Res 2000;448:91\u201395.","journal-title":"Mutat Res"},{"key":"2307_CR17","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00007691-200406000-00017","volume":"26","author":"T. Kubota","year":"2004","unstructured":"Kubota T, Nishida A, Takeuchi K, Takeuchi K, Iida T, Yokota H, et al. Frequency distribution of thiopurine S-methyltransferase activity in red blood cells of a healthy Japanese population. Ther Drug Monit 2004;26:319\u2013321.","journal-title":"Ther Drug Monit"},{"key":"2307_CR18","first-page":"694","volume":"58","author":"H.L. Tai","year":"1996","unstructured":"Tai HL, Krynetski EY, Yates CR, Loennechen T, Fessing MY, Krynetskaia NF, et al. Thiopurine S-methyltransferase deficiency: two nucleotide transitions define the most prevalent mutant allele associated with loss catalytic activity in Caucasians. Am J Hum Genet 1996;58:694\u2013702.","journal-title":"Am J Hum Genet"},{"key":"2307_CR19","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1007\/s00535-003-1139-2","volume":"38","author":"T. Hibi","year":"2003","unstructured":"Hibi T, Naganuma M, Kitahora T, Kinjo F, Shimoyama T. Low dose azathioprine is effective and safe for maintenance of remission in patients with ulcerative colitis. J Gastroenterol 2003;38: 740\u2013746.","journal-title":"J Gastroenterol"},{"key":"2307_CR20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/clpt.1994.4","volume":"55","author":"H.L. McLeod","year":"1994","unstructured":"McLeod HL, Lin JS, Scott EP, Pui CH, Evans WE. Thiopurine methyltransferase activity in American white subjects and black subjects. Clin Pharmacol Ther 1994;55:15\u201320.","journal-title":"Clin Pharmacol Ther"},{"key":"2307_CR21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s002280100267","volume":"57","author":"A. Lowenthal","year":"2001","unstructured":"Lowenthal A, Meyerstein N, Ben-Zvi Z. Thiopurine methyltransferase activity in the Jewish population of Israel. Eur J Clin Pharmacol 2001;57:43\u201346.","journal-title":"Eur J Clin Pharmacol"},{"key":"2307_CR22","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s00439-002-0798-z","volume":"111","author":"S. Sumi","year":"2002","unstructured":"Sumi S, Marinaki AM, Arenas M, Fairbanks L, Shobowale-Bakre E-M, Rees DC, et al. Genetic basis of inosine triphosphohydrolase deficiency. Hum Genet 2002;111:360\u2013367.","journal-title":"Hum Genet"},{"key":"2307_CR23","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ymgme.2005.03.011","volume":"85","author":"T. Maeda","year":"2005","unstructured":"Maeda T, Sumi S, Ueta A, Fairbanks L, Shobowale-Bakre E-M, Rees DC, et al. Genetic basis of inosine triphosphate pyrophosphohydrolase deficiency in the Japanese population. Mol Genet Metab 2005;85:271\u2013279.","journal-title":"Mol Genet Metab"},{"key":"2307_CR24","first-page":"1664","volume":"54","author":"J.M. Dieren van","year":"2005","unstructured":"van Dieren JM, van Vuuren AJ, Kusters JG, Nieuwenhuis EE, Kuipers EJ, van der Woude CJ. ITPA genotyping is not predictive for development of side effects in AZA treated inflammatory bowel disease patients. Gut 2005;54:1664.","journal-title":"Gut"},{"key":"2307_CR25","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/00008571-200411000-00010","volume":"14","author":"R.B. Gearry","year":"2004","unstructured":"Gearry RB, Roberts RL, Barclay ML, Kennedy MA. Lack of association between the ITPA 94C>A polymorphism and adverse effects from azathioprine. Pharmacogenetics 2004;14:779\u2013781.","journal-title":"Pharmacogenetics"},{"key":"2307_CR26","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1136\/gut.49.5.656","volume":"49","author":"P.W. Lowry","year":"2001","unstructured":"Lowry PW, Franklin CL, Weaver AL, Szumlanski CL, Mays DC, Loftus EV, et al. Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide. Gut 2001;49:656\u2013664.","journal-title":"Gut"},{"key":"2307_CR27","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1111\/j.1572-0241.2007.01511.x","volume":"102","author":"N.K. Boer de","year":"2007","unstructured":"de Boer NK, Wong DR, Jharap B, de Graaf P, Hooymans PM, Mulder CJ, et al. Dose-dependent influence of 5-aminosalicylates on thiopurine metabolism. Am J Gastroenterol 2007;102: 2747\u20132753.","journal-title":"Am J Gastroenterol"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-008-2307-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-008-2307-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-008-2307-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T17:50:26Z","timestamp":1589565026000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-008-2307-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,13]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["2307"],"URL":"https:\/\/doi.org\/10.1007\/s00535-008-2307-1","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,13]]}}}